A new drug known as 2‐(anaphthoyl)ethyltrimethylammonium iodide (α‐NETA), a choline acetyltransferase inhibitor,226 hinders the development of epithelial ovarian cancer by activating pyroptosis via the GSDMD/caspase 4 pathway.227. The gene discussed is GSDMD; the disease is ovarian carcinoma.